Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

THE NOVEL USE OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF OF COMPLEMENT-MEDIATED DISEASES

  • Read more about THE NOVEL USE OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF OF COMPLEMENT-MEDIATED DISEASES
US Application 07/551,522
Filed on 1990-07-11

DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES

  • Read more about DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES
US Application 07/545,077
Filed on 1990-06-29

PERTUSSIS TOXIN GENE: CLONING AND EXPRESSION OF PROTECTIVE ANTIGEN

  • Read more about PERTUSSIS TOXIN GENE: CLONING AND EXPRESSION OF PROTECTIVE ANTIGEN
US Application 07/542,149
Filed on 1990-06-22

RAPID ENZYMATIC MEASUREMENT OF SERUM FLUCYTOSINE LEVELS

  • Read more about RAPID ENZYMATIC MEASUREMENT OF SERUM FLUCYTOSINE LEVELS
US Application 07/541,181
Filed on 1990-06-18

Recombinant Vaccinia Virus Containing a Chimeric Gene Having Foreign DNA Flanked by Vaccinia Regulatory DNA

  • Read more about Recombinant Vaccinia Virus Containing a Chimeric Gene Having Foreign DNA Flanked by Vaccinia Regulatory DNA
US Application 07/539,169
Filed on 1990-06-18

Nucleotide, Deduced Amino Acid Sequence, Isolation and Purification of Heat-Shock Chlamydial Protein

  • Read more about Nucleotide, Deduced Amino Acid Sequence, Isolation and Purification of Heat-Shock Chlamydial Protein
US Patent 5,071,962
Filed on 1990-05-31

VERSATILE REAGENT FOR DETECTING MURINE LEUKEMIA VIRUSES

  • Read more about VERSATILE REAGENT FOR DETECTING MURINE LEUKEMIA VIRUSES
US Application 07/528,714
Filed on 1990-05-24

PEPTIDE DERIVATIVES OF CYTOCHROME B558 AND THEIR USE AS MEDICAMENTS

  • Read more about PEPTIDE DERIVATIVES OF CYTOCHROME B558 AND THEIR USE AS MEDICAMENTS
US Patent 5,593,966
Filed on 1990-05-24

ADENO-ASSOCIATED VIRUS (AAV)-BASED EUCARYOTIC VECTORS

  • Read more about ADENO-ASSOCIATED VIRUS (AAV)-BASED EUCARYOTIC VECTORS
US Application 07/527,195
Filed on 1990-05-23

COEXPRESSION AND INTERACTION OF TWO SUBUNITS OF VACCINIA VIRUS CAPPING ENZYME

  • Read more about COEXPRESSION AND INTERACTION OF TWO SUBUNITS OF VACCINIA VIRUS CAPPING ENZYME
US Application 07/521,682
Filed on 1990-05-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 580
  • Page 581
  • Page 582
  • Page 583
  • Page 584
  • Page 585
  • Page 586
  • Page 587
  • Page 588
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health